Drug profile · INN
recombinant coronavirus (sars-cov-2) vaccine
COVGOZE
recombinant coronavirus (sars-cov-2) vaccine (COVGOZE) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — recombinant coronavirus (sars-cov-2) vaccine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
recombinant coronavirus (sars-cov-2) vaccine (COVGOZE) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN recombinant coronavirus (sars-cov-2) vaccine
Brand COVGOZE
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is recombinant coronavirus (sars-cov-2) vaccine?
recombinant coronavirus (sars-cov-2) vaccine (COVGOZE) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for recombinant coronavirus (sars-cov-2) vaccine?
COVGOZE is a marketed brand name for recombinant coronavirus (sars-cov-2) vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.